KRAS signaling provides a competitive advantage to cancer cells by participating in central carbon metabolism, increasing glucose uptake and glycolysis to increase the nutrients flux while promoting multiple branching biosynthetic pathways. The gene discussed is KRAS; the disease is cancer.